Entertainment
Vivebiotech Secures Growth Investment From Ampersand Capital Partners To Expand Lentiviral Vector Development And Manufacturing Capabilities
(MENAFN - PR Newswire) SAN SEBASTIAN, Spain, Dec. 4, 2024 /PRNewswire/ -- VIVEbiotech, a leadinglentiviral vector Contract Development and Manufacturing Organization (CDMO), today ...
By: menafn
- Dec 04 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS